ESR1-Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast Cancer.

Saved in:
Bibliographic Details
Title: ESR1-Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast Cancer.
Authors: Bonechi F; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Bacci M; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Lorito N; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Smiriglia A; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Subbiani A; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Pagliantini E; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Comito G; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Gangarossa G; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Duatti A; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., El Botty R; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, Paris, France., Sourd L; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, Paris, France., Romano E; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Tani G; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Segatto I; Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, Aviano, Italy., Belletti B; Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, Aviano, Italy., Meattini I; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.; Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy., Livi L; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.; Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy., Cerbelli B; Department of Medico-Surgical Sciences and Biotechnologies, Policlinico Umberto I University Hospital, Sapienza University of Rome, Rome, Italy., Botticelli A; UOC Oncologia A, Department of Hematology, Oncology and Dermatology, Policlinico Umberto I University Hospital, Sapienza University of Rome, Rome, Italy., Fiorillo M; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy., Marangoni E; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, Paris, France., Morandi A; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Source: Cancer research [Cancer Res] 2026 Feb 02; Vol. 86 (3), pp. 679-692.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-25-1339